NIH-funded research R01 grant

Investigating how S-nitrosylation affects heart signaling during injury and repair

Official title: Role of S-Nitrosylation on Beta-Adrenergic Signaling in Cardiac Injury and Repair

Funded at Duke University · NIH-11002881 · Data updated 2026-11-12

This study is looking at how a special process in the heart, called S-nitrosylation, affects the way heart cells communicate, especially after an injury, to find new ways to help protect the heart and improve its function for people with heart failure.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionDuke University
NIH-funded
Lab location1 site (Durham, United States)
Project startDecember 22, 2023
Project endMarch 31, 2026
Funding year2024
Award (this year)$724,176
NIH project number7R01HL157151-04
Project IDNIH-11002881 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with heart failure or those who have experienced cardiac injuries.

Less likely to help

Patients with non-cardiac related health issues or those without heart conditions may not benefit from this research.

What this research studies

This research focuses on understanding the role of S-nitrosylation in the signaling pathways of beta-adrenergic receptors in the heart, particularly during and after cardiac injury. By examining how nitric oxide influences these pathways, the study aims to uncover mechanisms that could protect heart cells from damage and improve heart function. The researchers will utilize advanced genetic models and biochemical techniques to explore the effects of S-nitrosylation on key proteins involved in heart signaling. This could lead to new therapeutic strategies for heart failure and related conditions.

Why it matters

Potential benefit: If successful, this research could lead to innovative treatments that enhance heart recovery and function after injury.

How similar studies have gone: Previous research has shown promising results in understanding the role of nitric oxide in cardiac signaling, suggesting that this approach could yield significant insights.

Where this research is happening

  • Duke University
    Durham, United States
    Active

Researchers

  • Principal investigator: Koch, Walter J. — Duke University
  • Study coordinator: Koch, Walter J.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.